Harbor president and founder Jerry Mezger said the company is happy to gain FDA clearance for its Architect, which helps to treat a wide variety of serious skin wounds, including diabetic foot ulcers, venous leg ulcer, pressure ulcers, and many other trauma or surgery related skin wounds.
"These serious wounds affect about 6 million Americans each year," Mezger added.
"They not only are a leading cause of infection, hospitalization and even amputation, but the cost of today’s therapies is a major burden on the healthcare system."
According to Mezger, the FDA’s approval allows the company to provide a unique wound treatment alternative to hospitals and wound care clinics that offer not only earlier and more aggressive therapy, but at a substantially lower cost than today’s leading products.
